International cooperation to address and counter the world drug problem A/RES/72/198 that are involved in any activities related to the illicit production of and trafficking in narcotic drugs and psychotropic substances and the diversion of their precursors and related money-laundering; 54. Reiterates the commitment of Member States to share relevant information with, as appropriate, and strengthen the capacity of the World Health Organization, the United Nations Office on Drugs and Crime, the International Narcotics Control Board and other relevant international and regional organizations to prioritize the review of the most prevalent, persistent and harmful new psychoactive substances and to facilitate informed scheduling decisions by the Commission on Narcotic Drugs; 55. Encourages Member States to enhance the capacity of law enforcement agencies to detect and identify new psychoactive substances and amphetamine -type stimulants, including methamphetamine, and promote cross -border cooperation and information-sharing to prevent their abuse and diversion, including through the use of existing International Narcotics Control Board and United Nations Office on Drugs and Crime tools and projects; 56. Also encourages Member States to establish and strengthen partnerships and information exchange with industries, in particular with chemical and pharmaceutical industries and other relevant private sector entities, and encourage the use of the Guidelines for a Voluntary Code of Practice for the Chemical Industry , issued by the International Narcotics Control Board, and the Board’s model memorandum of understanding between Governments and private sector partners, as and where appropriate, bearing in mind the important role these industries can play in addressing and countering the world drug problem; 57. Calls upon Member States to commit to implementing timely, scientific evidence-based control or regulatory measures within national legislative and administrative systems to tackle and manage the challenge of new psychoactive substances, and to consider the use of interim steps while substances are under review, such as provisional measures of control, or to make public health announcements, as well as share information and expertise on those measures; 58. Invites Member States to support existing research, collection and scientific analysis of data related to amphetamine-type stimulants through the global Synthetics Monitoring: Analysis, Reporting and Trends (SMART) programme and relevant International Narcotics Control Board tools, such as Project Pr ism, and strengthen cooperation at all levels in tackling amphetamine -type stimulants, including methamphetamine; 59. Also invites Member States to promote the use, as appropriate, of relevant existing programmes, mechanisms and coordinated operations at all levels and continue the development and sharing of best practices and lessons learned among practitioners with regard to a balanced and integrated approach to the evolving threat of amphetamine-type stimulants; 60. Calls upon Member States to continue efforts to identify and monitor trends in the composition, production, prevalence and distribution of new psychoactive substances, as well as patterns of use and adverse consequences, and assess the risks to the health and safety of individuals and society as a whole and the potential uses of new psychoactive substances for medical and scientific purposes, and on that basis to develop and strengthen domestic and national legislative, regulatory, administrative and operational responses and practices by d omestic and national legislative, law enforcement, judiciary, social and welfare, educational and health authorities; 17-23200 13/21